Shanghai Haohai Biological Technology’s $40 Million Investment in Eirion Therapeutics

Locke Lord LLP advised Shanghai Haohai Biological Technology Co. on the deal.Shanghai Haohai Biological Technology Co., Ltd., a public company traded on the Hong Kong and…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now